chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Vaccination Thursday 9/14/2023 @ 3pm. Followed by: -Higher temperature 99.8 -Tired earlier  Friday 9/15 -Large red bump with jewel on right scapula/shoulder found at 8am -Red bump in left armpit with surrounding area irritated found at 1pm -Red bump below pelvis found at 1pm  Saturday 9/16 -Second red bump below pelvis -Scap/Shoulder bump begins to drain -Pale poop  Tuesday 9/19 - Small red bump on left cheek  Thursday 9/21 -Small rash surrounding scap/shoulder bump
Patient reporting fever, chills, pain, redness, warmth, swelling at injection site. Will seek medical attention from physician.
14 Hours after my 2nd dose (Pfizer) vaccine, I had the worse flu like symptoms I've ever head.  It hit me around 1:20 in the morning.  That was something that I knew could be a possible side effect, but the next several days I had was seemed like a cold (sneezing, stuffy nose, itchy watery eyes, sore throat).  The alarming side effect was hives/rash.  This appeared within 3 days of my vaccine.  They started on both of my arms and then it went to both of my legs and then eventually on part of my back and stomach.  I went to my dermatologist and they gave me steroid cream, when that didn't work, they gave me the steroid pack, and then I had to have a steroid shot as nothing was working.  I went to an allergist who thought it might be chronic hives so they started me on Xolair injections.  During all of this my menstrual cycle was extremely chaotic.  I would bleed multiple times a month and up to 17 days in a row.  I had 3 doses of Xolair (May, June, July).  My hives/rash have calmed down now and I am no longer taking Xolair.  After a battery of blood tests, etc., my doctors believe this was a reaction that my body had to the vaccine.  I have no known allergies.  I was very much encouraged by my primary care physician to submit my situation to the CDC to possibly help other woman.  I'm terrified to get the booster that was announced that is now recommending us to get.
Right arm weakness since flu shot given on 10/23/2003. Follow up 1/19/04: Follow up visits with patient are much more consistent with rotator cuff pathology as the etiology of his shoulder paina nd weakness than his initial assertion that it was due to his flu shot.
This spontaneous report as received from a pharmacist refers to a 53 years old male patient with seasonal allergy, no pertinent medical history and no drug reactions or allergies. The patient was vaccinated with a 0.65 ml dose of ZOSTAVAX (Lot # 0423AE expiration date 02-APR-2013) SQ on 31-AUG-2012. No other co-suspects were reported. Concomitant medications included NASONEX and PATANOL. The pharmacist reported that on an unknown date, "several months" after administration of ZOSTAVAX, the patient experienced severe itching around injection site. The patient described the itching to pharmacist as internal itching where there was no other rash or lesion but patient had been experiencing itching on and off since the administration back in August 2012. The patient also complained that he had been sneezing a lot more and experienced worsening of his seasonal allergy symptoms since ZOSTAVAX administration. There were no Lab diagnosis/studies performed. At the time of the report, the patient's outcome was unknown. Additional information has been requested.
Narrative:  8/26/21: Hospice service for end of life care. HIs medical issues include newly diagnosed HIV/AIDS, currently not on therapy, recent admission for disseminated cryptococcal infection, brain mass, lung mass, Legionella pneumonia, HCAP, deconditioning, anorexia/weight loss, encephalitis/delirium.
Information has been received from a physician concerning a 14 year old patient who on an unspecified date, was vaccinated with a dose of GARDASIL (lot number unspecified) and fainted post vaccination.  The physician was not certain if the event occurred after the patient's first or second vaccination with GARDASIL but knew it was definitely not with administration of the third dose.  Additional information has been requested. This is in follow-up to report(s) previously submitted on 5/14/2008. Initial and follow-up information has been received from a physician and from a nurse practitioner concerning a 14 year old female with allergy to penicillin, who on an unspecified date was vaccinated with a second dose of GARDASIL (lot number unspecified), fainted and was pale post vaccination. Subsequently, the patient recovered from her experiences. No other information was available. This is one of several reports received from the same source. Additional information is not expected.
My first dose was on 03/03 and second dose on 04/01. I found out I was pregnant on 10/10/20 with an expected due date of 06/15/21. I was induced on 06/15 and gave birth on 06/18/21. Our baby girl was born at 6 lbs. 12 oz. and 19.5 inches. She was diagnosed with Bell's Palsy. It is isolated to the right side of her face affecting her forehead, eye, nostril, eyebrow, lips, and tongue.
About 5 minutes after receiving the shot, I started having intense dizziness, and nausea, and my body felt very hot. My eyes teared up  as well.  This feeling subsided a little after 15 more minutes, so I went home.  At home (and within 30 minutes of receiving the vaccine), the lymph nodes in my throat swelled considerably and I had great difficulty speaking.  Having experienced anaphylaxis in the past, this was not anaphylaxis but something else entirely - it was like my vocal cords were paralyzed.  I took ibuprofen to help with the swelling, but it did not seem to impact my throat or ability to speak. About 4 hours later my throat muscles seemed to loosen and I was able to speak fairly normally again.
abnormal EKG; dizziness; lightheadedness; This is a spontaneous report from a contactable consumer. A 78-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection. Lot Number: EN6202), dose 1 via an unspecified route of administration on 23Feb2021 as 1st single dose for COVID-19 immunization. Patient had long history of motion sickness. Concomitant medications included dimenhydrinate (DRAMAMINE) and meclizine hcl (MECLIZINE HCL) both taken for motion sickness. On 23Feb2021, the patient experienced dizzy so patient went to bed early, feeling lightheaded, and patient sits most of the time instead of moving around the house. Slight dizziness was a concern because it has been 9 days. Patient want to know if it will go away by itself, or if she needs to do something and if this is a normal reaction to the vaccine, how long it will take for the symptoms to subside. Patient dizziness has lasted nine days and patient would like to know if it was a side effect or if it could be Meclizine. Patient want to reschedule 2nd dose and wait until the side effects go away before receiving the 2nd dose and want to know the medication had an interaction with the vaccine and it would be safe for her to take Meclizine before she receives 2nd dose. Patient wonders if there could have been a vaccine interaction with Dramamine or Meclizine that patient took that afternoon. Patient taking Meclizine since before vaccination, but patient did not think it worked that day. Patient wanted to know if it was safe to take dramamine chewable before the COVID-19 vaccine and what would happen if patient only gets one dose. The patient underwent lab tests and procedures which included electrocardiogram: abnormal. She had an abnormal EKG when patient went to urgent care last Friday on 05Mar2021 and also she went to the urgent care for dizziness and light headedness that experienced since first dose. Patient did not know if the dizziness and light headedness are related to the vaccine. Patient wanted to know if it was safe to get the second dose with an abnormal EKG. The outcome of the events were unknown.
death; shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a 61-year-old male patient. No information was provided regarding medical history, concurrent conditions, or concomitant medications. On 23-SEP-2017, the patient was inoculated with zoster vaccine live (ZOSTAVAX) (lot#, expiration date, exact dose, dose# and route not specified) at a pharmacy. On an unknown date in 2017, reported as within one month after receiving zoster vaccine live (ZOSTAVAX), and as a result of his receipt of zoster vaccine live (ZOSTAVAX), the patient was caused to suffer shingles, including any and all of its sequelae. As a result of his receipt of zoster vaccine live (ZOSTAVAX), the patient had been caused to suffer severe personal injuries, pain, suffering and emotional distress, as well as to incur substantial economic damages. On an unknown date, the patient died. The cause of death and if autopsy was done was unknown. The outcome of the event of shingles was not reported. The reporter considered the event of shingles to be related to zoster vaccine live (ZOSTAVAX). The relatedness between the event of death and zoster vaccine live (ZOSTAVAX) was not reported.
Small sores; small, itchy on my torso; This case was reported by a consumer via interactive digital media and described the occurrence of skin ulcer in a patient who received Herpes zoster (Zoster vaccine) for prophylaxis.   On 16th October 2022, the patient received the 1st dose of Zoster vaccine. In 2022, less than 3 weeks after receiving Zoster vaccine, the patient experienced skin ulcer and pruritus. On an unknown date, the outcome of the skin ulcer and pruritus were not recovered/not resolved.   It was unknown if the reporter considered the skin ulcer and pruritus to be related to Zoster vaccine.     Additional Information: GSK receipt date :04-NOV-2022 Reporters comment: This case was reported by a consumer via interactive digital media.. The patient received first dose of shingrix vaccine and experienced small sores and itching on his/her torso.
Headache; This case was reported by a consumer via call center representative and described the occurrence of headache in a 68-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced headache. On an unknown date, the outcome of the headache was recovered/resolved.   It was unknown if the reporter considered the headache to be related to Shingrix.  Additional case details were reported as follows: The age at vaccination was not reported. The patient had headache for 3 days.  The reporter did not have additional information.
Approx 5 min p/inject pt legs turned rosy red & warm to touch & pt was still crying; encouraged pt to wait for clinic MDs  to arrive in approx 5 min, but mom left saying was going to ER; ER phoned by clinic but pt did not arrive;
COVID-19 Vaccine #1 received on 12/29/20 @11:40am- That afternoon, mild soreness @ injection site. 12/30/21- moderate pain in upper arm and sharp, stabbing pain in axilla (injection site side). Unable to lift arm straight up due to pain. Evening: Myalgia/joint pain, fatigue, nausea, mild headache. Took Tylenol and Phenergan.  12/31/21- Woke up at 4am with pain in axilla-took tylenol. Moderate pain in upper arm and axilla. Unable to palpate axilla due to pain while at work. Evening: axillary lymphadenopathy noted- walnut sized. Severe myalgia/joint pain, fatigue, nausea, headache, malaise. Took Motrin and Phenergan. Woke up in middle of night with pain in arm/axilla and nausea. took tylenol and zofran. 1/1/21- Worst day of symptoms. Moderate-severe pain in upper arm and axilla. Golf ball sized lymphadenopathy in axilla on injection side. Severe weakness, dizziness, fatigue, myalgia, and joint pain. Low grade temp (99.7), tachycardia (HR averaged 110-115), shortness of breath on exertion with associated tachypnea (RR 24-26). No appetite and nausea. Stayed in bed ALL DAY. Alternated Tylenol/ Motrin, Benadryl & Zofran as needed. Only reason I did not go to ED is because I had a pulse oximeter at home was monitoring O2 sats closely. Never de-sat'ed. Had I not had the pulse ox at home, I would've gone to ED.  In the evening, had lymphadenopathy in neck also (same side as injection).  1/2/21- Most symptoms have dissipated except axillary lymphadenoapthy- axilla incredibly tender-golf ball sized. Lymph nodes in neck still palpably enlarged.  1/3/21- Lymph nodes in neck normal. Axillary lymphadenopathy remains with same tenderness.  1/4/21 AM- NO change in axillary lymphadenopathy-tenderness same
VDay,   7pm: Muscle Aches (minor) VDay+1 ,  4am : Fever (103), Chills, Muscle Aches VDay+1,  8am-8pm : Fever(101), Muscle Aches VDay+2, 6am :  Recovered
Fever, chills and nausea. Took ibruprofen and slept, felt better in about 8 hours
1st dose on 09JAN2023, 2nd on 30JAN2023; This case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too short in a 75-year-old female patient who received Herpes zoster (Shingrix) (batch number 5L3HB, expiry date 20th May 2024) for prophylaxis.   Concomitant products included VARICELLA ZOSTER VACCINE RGE (CHO) (SHINGRIX).   On 30th January 2023, the patient received the 2nd dose of Shingrix. On 30th January 2023, unknown after receiving Shingrix and an unknown time after receiving SHINGRIX, the patient experienced drug dose administration interval too short. On an unknown date, the outcome of the drug dose administration interval too short was unknown.   Additional Information: GSK Receipt Date: 31-JAN-2023 Reporter's Comments: Pharmacist administered to a female adult a Shingrix second dose earlier than recommended by GSK. First dose was on 9th January 2023 and second dose was administered on 30th January 2023. He did not have any information about his HCP. The reporter consented to follow-up via email. HCP´S details are shared on this report Additional Supportive Information: the patient received 2nd dose on 30th January 2023, earlier than recommended schedule, which led to shortening of vaccination schedule.
I tested positive for COVID 19 after. Fatigue, sore throat, chills, headache, total body aches, nausea, vomiting, loss of taste and loss of smell, chest pressure, and dizziness. Worsened after pervious VAERS report but now has resolved.
arm was red; Arm is swollen; purple spots that turned into a sore like rash; itching; rash in her genital area; extreme itching on arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (arm was red), VACCINATION SITE SWELLING (Arm is swollen), VACCINATION SITE RASH (purple spots that turned into a sore like rash), PRURITUS (itching) and GENITAL RASH (rash in her genital area) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (arm was red), VACCINATION SITE SWELLING (Arm is swollen), VACCINATION SITE RASH (purple spots that turned into a sore like rash), PRURITUS (itching), GENITAL RASH (rash in her genital area) and PRURITUS (extreme itching on arm). At the time of the report, VACCINATION SITE ERYTHEMA (arm was red), VACCINATION SITE SWELLING (Arm is swollen), VACCINATION SITE RASH (purple spots that turned into a sore like rash), PRURITUS (itching), GENITAL RASH (rash in her genital area) and PRURITUS (extreme itching on arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.        No relevant concomitant medications were reported  No treatment information was provided.
This spontaneous report as received from two pharmacists (one via field representative) refers to a patient of unknown age. On 10-SEP-2013 the patient was vaccinated with ZOSTAVAX vials of lot number J001700 and expiry date 08-MAY-2014. Dose and route were unspecified. The reporter informed that one shipment of improperly stored ZOSTAVAX vials (lot number J001700 and expiry date 08-MAY-2014) received on 27-JUN-2013 were exposed to 5 degrees centigrade for possibly 105 days. The patient had been administered with the improperly stored vaccine. No adverse event was reported. This is 2 of several reports from the same reporter. Additional information has been requested.
Dizziness, Shortness of breath, Irregular Heartbeat Diagnosed with Atrial Fibrillation on 4/13/21 by primary healthcare physician
Patient is a 69y.o. year old male who presented to the emergency department at Hospital with a chief complaint of fatigue.  Of note, patient was recently discharged from the hospital and was treated for pulmonary embolism and COVID-19 pneumonia.  Patient was noted to have low blood pressure recording as documented by his wife at home with values being 70s?80s.  Upon arrival to the emergency department, systolic blood pressure was noted to be in the 70s.  This past medical history includes end-stage renal disease on hemodialysis on Mondays, Wednesdays and Fridays, coronary artery disease, type 2 diabetes mellitus, bilateral below-knee amputation, distal right upper extremity amputation.  Patient reports adherence to hemodialysis sessions and prescribed medications.  Per chart review, it is noted that patient has very difficult to measure blood pressure via noninvasive route.  He denies fevers, chills, abdominal pain, cough or shortness of breath.  He is on 3 L nasal cannula, which is his home oxygen setting.  He does report poor oral intake secondary to decreased appetite.  No diarrhea.
Immediate pain upon injection. Burning sensation down left arm. Within a few minutes dizziness/disorientation. 3/19/21 at 1 AM wake to joint pain. Any injury, i.e. broken bone, sprain, etc. ever had was now inflamed & painful. Awake for 2 days due to pain. Overall muscle weakness. Attempted to "carry on" except the worst symptom appeared, BRAIN FOG. Could not remember words that started with s, sc, sh, etc. Would lose my car in parking lots. Couldn't finish sentences. Saw primary care physician on 3/26/21. Ordered MRI w/o contrast on 4/14with no acute process or findings to report. Saw masseuse on 3/26/21 & she wanted to know, "Why are you joints hot?" Symptoms began to subside around 4/19/21.
Within 2 hours of 2nd shot Ibegan to feel weak and began vomiting around 6pm.  Also having diarrhea in ileostomy bag.  I did not sleep Monday 3-8 night.   Vomiting .stopped the next day.  Little appetite.   Temp 3/11 was 99.3   slightly high.   No adverse event after first dose 2/15/21.
On the fourth day after receiving the vaccine, I developed a rash in the anterior and posterior thoracic region consisting of dispersed 1mm - 3mm size dots ranging from the clavicle to the pelvic region. These dots appeared in a diagonal, going from superior and lateral to inferior and medial. On the second day of noticing the rash the bumps appeared as if they were blistering. No medication was used at this time.
Injection site is swollen; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Injection site is swollen) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE SWELLING (Injection site is swollen). At the time of the report, VACCINATION SITE SWELLING (Injection site is swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were mentioned.  No treatment details were reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Patient received 1st dose of Pfizer vaccine.  5 minutes later, patient felt light-headed, shaky, sweaty and pale. Gave patient juice and ice. 20 minutes later, patient was feeling fine.
This spontaneous report was received from a certified medical assistant refers to a 6 month old female patient. Medical history was not reported. On an unknown date the patient was vaccinated with the first dose of ROTATEQ oral, (lot number, expiration date and dosage were not reported). Concomitant therapy was not reported. The medical assistant informed that on an unknown date the patient received only one dose of ROTATEQ. The medical assistant asked if there was anything wrong with that or if was it contraindicated after any certain point. The medical assistant informed that the patient should have started at 2 months but she missed those immunizations so they wanted to give at least one dose. Additional information has been requested.
PT GOT THE FIRST DOSE FROM MODERNA  AND SECOND DOSE PFIZER( A MISMATCH)
No adverse reactions but patient was under the age of 12 at the time of he administration. No physiological alterations occurred to the patient as confirmed with questions answered by parents and review of observation report from on site dated 08/14/2021
unusual crusty thing on her arm as a side effect; red spot; This is a spontaneous report from a contactable consumer (Patient). A 64-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE: Solution for injection), dose 2 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunisation and tocilizumab (ACTEMRA), route of administration, start and stop date, batch/lot number and dose were not reported for an unspecified indication. Medical history included rheumatoid arthritis from an unknown date and unknown if ongoing (RA for several years). On an unspecified date, the patient experienced unusual crusty thing on her arm as a side effect on an unspecified date and red spot. The action taken in response to the events for bnt162b2 was not applicable. The outcome of event was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
extreme version of COVID 19 symptoms: extremely hard to breathe only able to take short breaths; vomiting; dry-heaves; coughing; no appetite; fever; cold sweats; chills; lethargy; tired; no energy 15 lb weight loss. This continued from Mid May to June 10, 2021.
COVID-19 confirmed by positive COVID-19 test; COVID-19 confirmed by positive COVID-19 test; This is a spontaneous report from a Pfizer Sponsored Program. A contactable consumer (patient) reported that a patient of an unspecified age and gender received BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 2 via an unspecified route of administration on an unknown date (Lot Number: Unknown) as single dose, dose 1 via an unspecified route of administration on an unknown date (Lot Number: Unknown) as single dose; both for covid-19 immunization. Medical history and concomitant medications were not reported. After 10 days of the second shot, the patient underwent COVID 19 test which showed positive result. The outcome of the events were unknown.  Forwarded as an Adverse Event by the Epsilon Escalation team on 04May2021. Reporter provided verification of contact address on 04Mar2021.  Information on the lot/batch number has been requested.
Pt received COVID vaccine at hospital 01/4/2021.  She was seen in PCP office 01/19/2021 and given Hep A and Tdap vaccines, which now prevents her from receiving her 2nd COVID vaccine.  1/21/2021 Called pt and left her a detailed message letting her know that she should wait the full 14 days to get the COVID vaccine and that even though she will be a day past the 28 day window for her COVID vaccine series, she should still be able to get it and not have to restart the series.